Dr Bijoy Menon presents breakthrough stroke treatment research at CNSF 2022 Congress
Large Canadian randomized trial shows that Tenecteplase is the preferred thrombolytic drug for stroke
UCalgary researchers with the Calgary Stroke Program make another breakthrough in the treatment of stroke
Study shows a heart attack drug can become the standard treatment for acute ischemic stroke. Learn more..
Posted Wednesday, June 29, 2022